Clinical Trials Update: Dec. 19, 2005

Claudication Sinus Infections Bone Density

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Claudication

This study is looking for individuals to participate in a research study of an investigational drug thought to grow or improve blood vessels as an alternative to surgery.

The trial is testing the ability of this drug to improve your ability to exercise and improve your quality of life. Successful candidates must be at least 40 years old, having leg pain when walking, be able to walk on a treadmill, be cancer free for the past five years, and in be good health for the past three months.

The research site is in Raleigh, N.C.

More Information

Please see http://www.centerwatch.com/patient/studies/cat391.html.

-----

Sinus Infections

If you are 18 years or older and have been diagnosed with a sinusitis Infection, you may qualify to participate in a clinical trial of an investigational antibiotic to treat sinus infections.

Successful candidates must have at least two of the following current symptoms lasting longer than 7 days and less than 28 days: facial pain or pressure, frontal headaches, purulent nasal discharge, post nasal drip, maxillary dental and pain or fever.

The research site is in San Luis Obispo, Cal.

More Information

Please see http://www.centerwatch.com/patient/studies/cat184.html.

-----

Bone Density

The purpose of this research study is to evaluate the safety of the drug Etanercept (enbrel) to determine if it can help in the treatment of early bone marrow failure in patients with Fanconi anemia.

Patients must be at least four years old and be diagnosed with Fanconi anemia (FA). A screening evaluation including a medical history, physical exam, blood tests, chest x-ray, and bone marrow aspirate and biopsy is required.

The research site is in Cincinnati, Ohio.

More Information

Please see http://www.centerwatch.com/patient/studies/cat198.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News